Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clover Biopharmaceuticals
Biotech
Clover touts BA.5 data as wait for COVID-19 vaccine nod drags on
Clover is pitching its first-generation vaccine as a “universal booster”—and touting antibody levels against omicron BA.5 to make its case.
Nick Paul Taylor
Sep 20, 2022 6:30am
Clover's COVID booster bolsters antibody levels against omicron
Jun 27, 2022 11:10am
Clover's COVID-19 vaccine tames delta in pivotal study
Sep 22, 2021 8:55am
Clover raises $230M as COVID-19 vaccine nears phase 3
Feb 23, 2021 8:35am
Clover nears pivotal trial of GSK-adjuvanted COVID-19 vaccine
Dec 4, 2020 8:25am
Clover nabs another $250M-plus from CEPI for COVID-19 vaccine
Nov 3, 2020 12:36pm
